Browsing by Author Delgado, Julio (Delgado González)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
27-Aug-2013A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)Ojeda, Pedro; Piqué i Clusella, Núria; Alonso, Alicia; Delgado, Julio (Delgado González); Feo, Francisco; Igea, Juan Manuel; Navarro, Ana; Olaguibel, José María; Subiza, Javier; Nieto, Carles; Andersson, Morgan
24-Jun-2014Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.Baumann, Tycho; Delgado, Julio (Delgado González); Santacruz, Rodrigo; Martínez Trillos, Alejandra; Royo Moreno, Cristina; Navarro López, Alba; Pinyol, Magda; Rozman, María; Pereira Saavedra, Arturo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; López Alcalá, Cristina; Carrió, Ana; Montserrat Costa, Emilio
6-Dec-2018Development of a novel anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutionsCastella, Maria; Boronat, Anna; Martín Ibáñez, Raquel; Rodríguez, Vanina; Suñé, Guillermo; Caballero, Miguel; Marzal, Berta; Pérez-Amill, Lorena; Martín-Antonio, Beatriz; Castaño, Julio; Bueno, Clara; Balagué, Olga; González-Navarro, Europa Azucena; Serra Pagès, Carles; Engel Rocamora, Pablo; Vilella, Ramon; Benítez-Ribas, Daniel; Ortiz-Maldonado, Valentín; Cid Vidal, Joan; Tabera, Jaime; Canals i Coll, Josep M.; Lozano, Miquel; Baumann, Tycho; Vilarrodona, Anna; Trias, Esteve; Campo Güerri, Elias; Menéndez Buján, Pablo; Urbano Ispizua, Álvaro; Yagüe, Jordi; Pérez Galán, Patricia; Rives, Susana; Delgado, Julio (Delgado González); Juan, Manel
Nov-2014Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.Delgado, Julio (Delgado González); Salaverria Frigola, Itziar; Baumann, Tycho; Martínez Trillos, Alejandra; Lee, Eriong; Jiménez, Laura; Navarro López, Alba; Royo Moreno, Cristina; Santacruz, Rodrigo; López, Cristina; Payer, Ángel R.; Colado, Enrique; González, Marcos; Armengol, Lluís; Colomer Pujol, Dolors; Pinyol, Magda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Carrió, Ana; Costa, Dolors; Clot, Guillem; Giné Soca, Eva; López Guillermo, Armando; Campo Güerri, Elias; Beà Bobet, Sílvia M.
15-Mar-2016Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.Delgado, Julio (Delgado González); Bielig, Torsten; Bonet, Lizette; Carnero-Montoro, Elena; Puente, Xose S.; Colomer Pujol, Dolors; Bosch, Elena; Campo Güerri, Elias; Lozano Soto, Francisco
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez Carabaza, Neus; Martínez Trillos, Alejandra; Montraveta, Arnau; López-Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio (Delgado González); Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, Maria José; Navarro, Blanca; Colado, Enrique; Payer, Ángel R.; Puente, Xose S.; López-Otin, Carlos; López Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
20-Mar-2020Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical TrialCastella, Maria; Caballero Baños, Miguel; Ortiz Maldonado, Valentín; González Navarro, Europa Azucena; Suñé, Guillermo; Antoñana Vildosola, Asier; Boronat, Anna; Marzal, Berta; Millán, Lucía; Martín-Antonio, Beatriz; Cid Vidal, Joan; Lozano, Miquel; García, Enric; Tabera, Jaime; Trias, Esteve; Perpiña, Unai; Canals i Coll, Josep M.; Baumann, Tycho; Benítez-Ribas, Daniel; Campo Güerri, Elias; Yagüe, Jordi; Urbano Ispizua, Álvaro; Rives, Susana; Delgado, Julio (Delgado González); Juan, Manel
18-Jan-2011Practical Aspects of Allogeneic Hematopoietic Cell Transplantation for Patients with Poor-risk Chronic Lymphocytic LeukemiaDelgado, Julio (Delgado González); Duarte, Rafael
Feb-2019Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.Baliakas, Panagiotis; Moysiadis, Theodoros; Hadzidimitriou, Anastasia; Xochelli, Aliki; Jeromin, Sabine; Agathangelidis, Andreas; Mattsson, Mattias; Sutton, Lesley-Ann; Minga, Eva; Scarfò, Lydia; Rossi, Davide; Davis, Zadie; Villamor i Casas, Neus; Parker, Helen; Kotaskova, Jana; Stalika, Evangelia; Plevova, Karla; Mansouri, Larry; Cortese, Diego; Navarro López, Alba; Delgado, Julio (Delgado González); Larrayoz, Marta; Young, Emma; Anagnostopoulos, Achilles; Smedby, Karin E.; Juliusson, Gunnar; Sheehy, Oonagh; Catherwood, Mark; Strefford, Jonathan C.; Stavroyianni, Niki; Belessi, Chrysoula; Pospisilova, Sarka; Oscier, David; Gaidano, Gianluca; Campo Güerri, Elias; Haferlach, Claudia; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas
May-2014The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.Santacruz, Rodrigo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Martínez Trillos, Alejandra; López, Cristina; Navarro López, Alba; Rozman, María; Beà Bobet, Sílvia M.; Royo Moreno, Cristina; Cazorla, Maite; Colomer Pujol, Dolors; Giné Soca, Eva; Pinyol, Magda; Puente, Xose S.; López-Otin, Carlos; Campo Güerri, Elias; López Guillermo, Armando; Delgado, Julio (Delgado González)